EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epstein–Barr Virus in Brain Cancer—Friend or Foe?

Michał Brzozowski, Magdalena Góralczyk, Sylwester Bogacki iD, Małgorzata Polz-Dacewicz iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27114812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Michał Brzozowski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Department, 1st Clinical Military Hospital with Outpatient Clinic in Lublin, 20-049 Lublin, Poland. Hauptthemen laut MEDLINE: Brain Neoplasms, Herpesvirus 4, Human, Epstein-Barr Virus Infections, Glioma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin, Medical University of Lublin, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent research suggests a link between EBV and brain cancer, especially in high-grade gliomas, but its role has not been sufficiently elucidated. Therefore, we evaluated its occurrence in brain cancer. For this purpose, the EBV DNA and LMP-1 in tumor tissue, the level of viral load in the cerebrospinal fluid (CSF), and the serological status of patients were analyzed. We detected EBV DNA in 28.9% (42/145) of glioma samples, among which 28 were isolated from glioblastomas (GBs) and 14 from other gliomas. LMP-1 was detected in 26 (92.8%) GB samples and 5 (35.7%) samples from other gliomas. The EBV DNA load in the CSF was significantly higher in GB compared to other gliomas; anti-EBNA1, anti-EBVCA, anti-EA, and anti-Zta antibodies were detected in the serum of GB patients; and their concentration was higher in GB patients. Further research is needed to determine whether and to what extent EBV contributes to glioma development. Elucidating the role of latent EBV genes synthesized in glioblastoma is important for understanding the role of viral infection in cancer development and progression in this hitherto poorly studied area.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsHerpesvirus 4, HumanEpstein-Barr Virus InfectionsGliomaHumansFemaleDNA, ViralMaleViral LoadMiddle AgedGlioblastomaViral Matrix ProteinsAdultAgedAntibodies, ViralEpstein-Barr Virus Nuclear Antigens

Stichwörter der Autor:innen

EBVbrain cancerglioblastoma

Substanzen

DNA, ViralViral Matrix ProteinsEBV-associated membrane antigen, Epstein-Barr virusAntibodies, ViralEpstein-Barr Virus Nuclear Antigens

Autor:innen und Institutionen

  • Neurosurgery Department, 1st Clinical Military Hospital with Outpatient Clinic in Lublin, 20-049 Lublin, Poland.
  • Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, 20-059 Lublin, Poland.
  • Faculty of Administration and Social Sciences, University of Economics and Innovation, 20-209 Lublin, Poland.

ORCID-Profile: Sylwester Bogacki, Małgorzata Polz-Dacewicz

Förderung

  • Medical University of Lublin
  • Medical University of Lublin, Poland

Zitieren

APA

Brzozowski, M., Góralczyk, M., Bogacki, S., & Polz-Dacewicz, M. (2026). Epstein–Barr Virus in Brain Cancer—Friend or Foe?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27114812

Vancouver

Brzozowski M, Góralczyk M, Bogacki S, Polz-Dacewicz M. Epstein–Barr Virus in Brain Cancer—Friend or Foe?. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27114812

BibTeX
@article{Brzozowski2026,
  author = {Brzozowski, Michał and Góralczyk, Magdalena and Bogacki, Sylwester and Polz-Dacewicz, Małgorzata},
  title = {Epstein–Barr Virus in Brain Cancer—Friend or Foe?},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27114812}
}
Kostenlos starten →